A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL

Name: A Study of SGN-35 (Brentuximab Vedotin) of Patients With Relapsed or Refractory PMLBCL
License: Public Domain

Fondazione Italiana Linfomi - ETS

ClinicalTrials.gov · Datasets · License: Public Domain

primary mediastinal large b cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405146
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.